Olli-Pekka Kallioniemi · Finnish professor of molecular medicine (Karoliska Institutet) and director of SciLifeLab (Sweden); academy professor (Academy of Finland) · YYNN

Olli-Pekka Kallioniemi

? TBD

Finnish professor of molecular medicine (Karoliska Institutet) and director of SciLifeLab (Sweden); academy professor (Academy of Finland)

Ratings 0

Nobody has rated this yet. Be the first!

Works 20

BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition

Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count

scientific article published on 01 March 1990

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

Prognostic significance of dna index, multiploidy, and S-phase fraction in ovarian cancer

scientific article published on 01 January 1988

Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: A proposed classification of DNA histograms in breast cancer

scientific article published on 01 November 1988

ElevatederbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer

scientific article published on 01 February 1994

A strategy for identifying putative causes of gene expression variation in human cancers

Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity

scientific article published on 01 March 1988

High frequency of BRAF mutations in nevi

scientific article

Somatic STAT3 mutations in large granular lymphocytic leukemia

scientific article

Lists 0